Clinical studies have used schedules more intensive than those seen in recovery practice: patients with Parkinson's disease received 1,400 mg three times a week for four weeks (Hauser et al., Movement Disorders 2009, PMID 19230029), while studies on skin lightening used 1,200 mg twice a week for six weeks (Alzahrani et al., Cureus 2025, PMID 40013212)
doi: 10.1016/j.biopha.2019.109767 229 KatelanSKonjevodaSSaricAUrlicILovricICanovicSet al
Topical: Creams and serums offer targeted benefits with minimal risk
quick and effective This product has been great
The research also documented modest reductions in foods like dairy milk, alcohol, pork and starchy vegetables
That might mean titrating your dose, switching from semaglutide to tirzepatide (or vice versa), or recalibrating your protocol based on what the data shows